Clinical considerations in individuals with Alpha-1 Antitrypsin PI*SZ genotype (Q90280101)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32165400 AND SRC:MED&resulttype=core&format=json

12 April 2020

review article

1 reference

title

Clinical considerations in individuals with Alpha-1 Antitrypsin PI*SZ genotype (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32165400 AND SRC:MED&resulttype=core&format=json

12 April 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32165400 AND SRC:MED&resulttype=core&format=json

12 April 2020

author name string

Gerard N McElvaney

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32165400 AND SRC:MED&resulttype=core&format=json

12 April 2020

Robert A Sandhaus

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32165400 AND SRC:MED&resulttype=core&format=json

12 April 2020

Gerard M Turino

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32165400 AND SRC:MED&resulttype=core&format=json

12 April 2020

Niels Seersholm

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32165400 AND SRC:MED&resulttype=core&format=json

12 April 2020

Marion Wencker

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32165400 AND SRC:MED&resulttype=core&format=json

12 April 2020

Robert A Stockley

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32165400 AND SRC:MED&resulttype=core&format=json

12 April 2020

publication date

12 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32165400 AND SRC:MED&resulttype=core&format=json

European Respiratory Journal

12 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32165400 AND SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

12 April 2020

copyright license

start time

12 March 2020

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Liver Disease in Alpha1-Antitrypsin Deficiency Detected by Screening of 200,000 Infants

1 reference

12 December 2020

Lung function studies in asymptomatic individuals with moderately (Pi SZ) and severely (Pi Z) reduced levels of alpha1-antitrypsin

1 reference

12 December 2020

Liver involvement in infants with PiSZ phenotype of alpha 1-antitrypsin deficiency

1 reference

12 December 2020

Use of a highly purified alpha 1-antitrypsin standard to establish ranges for the common normal and deficient alpha 1-antitrypsin phenotypes

1 reference

12 December 2020

Neonatal hepatitis syndrome and alpha-1-antitrypsin deficiency: an epidemiological study in South-East England

1 reference

12 December 2020

Alpha 1 antitrypsin deficiency: clinical and physiological features in heterozygotes of Pi type SZ. A survey by the British Thoracic Association

1 reference

12 December 2020

Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects

1 reference

12 December 2020

Survival of patients with severe alpha 1-antitrypsin deficiency with special reference to non-index cases

1 reference

12 December 2020

Structural explanation for the deficiency of S alpha 1-antitrypsin

1 reference

12 December 2020

Clinical features of individuals with PI*SZ phenotype of alpha 1-antitrypsin deficiency. alpha 1-Antitrypsin Deficiency Registry Study Group

1 reference

12 December 2020

Baseline characteristics of enrollees in the National Heart, Lung and Blood Institute Registry of alpha 1-antitrypsin deficiency. Alpha 1-Antitrypsin Deficiency Registry Study Group

1 reference

12 December 2020

PI SZ phenotype in chronic obstructive pulmonary disease

1 reference

12 December 2020

Intermediate α1-antitrypsin deficiency PiSZ: a risk factor for pulmonary emphysema?

1 reference

12 December 2020

Genetics and respiratory disease. 2. Alpha 1-antitrypsin deficiency, cirrhosis and emphysema

1 reference

12 December 2020

Quantum proteolysis by neutrophils: implications for pulmonary emphysema in alpha 1-antitrypsin deficiency

1 reference

12 December 2020

Formation and current results of a patient-organized registry for alpha(1)-antitrypsin deficiency

1 reference

12 December 2020

Suppurative panniculitis associated with alpha 1-antitrypsin deficiency (PiSZ phenotype) treated with doxycycline

1 reference

12 December 2020

Alpha1-antitrypsin deficiency--a model for conformational diseases

1 reference

12 December 2020

American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency

1 reference

12 December 2020

Pattern of emphysema distribution in alpha1-antitrypsin deficiency influences lung function impairment

1 reference

12 December 2020

Outcome of PiSS and PiSZ alpha-1-antitrypsin deficiency presenting with liver involvement

1 reference

12 December 2020

Quantitative assessment of emphysema distribution in smokers and patients with alpha1-antitrypsin deficiency.

1 reference

12 December 2020

The protease inhibitor PI*S allele and COPD: a meta-analysis

1 reference

12 December 2020

Ongoing research in Europe: Alpha One International Registry (AIR) objectives and development

1 reference

12 December 2020

Alpha1-antitrypsin deficiency: current perspective on research, diagnosis, and management

1 reference

12 December 2020

Alpha-1 antitrypsin Null mutations and severity of emphysema

1 reference

12 December 2020

Outdoor air pollution is associated with disease severity in alpha1-antitrypsin deficiency

1 reference

12 December 2020

CT scan appearance, densitometry, and health status in protease inhibitor SZ alpha1-antitrypsin deficiency.

1 reference

12 December 2020

Alpha-1-antitrypsin phenotypes in adult liver disease patients

1 reference

12 December 2020

Diagnostic delay and clinical modifiers in alpha-1 antitrypsin deficiency

1 reference

12 December 2020

The discovery of α1-antitrypsin and its role in health and disease

1 reference

12 December 2020

The prevalence of alpha-1 antitrypsin deficiency in Ireland

1 reference

12 December 2020

A review of α1-antitrypsin deficiency

1 reference

12 December 2020

Serum levels and genotype distribution of α1-antitrypsin in the general population

1 reference

12 December 2020

Prevalence of α1-antitrypsin deficiency alleles PI*S and PI*Z worldwide and effective screening for each of the five phenotypic classes PI*MS, PI*MZ, PI*SS, PI*SZ, and PI*ZZ: a comprehensive review

1 reference

12 December 2020

Clinical phenotypes of Italian and Spanish patients with α1-antitrypsin deficiency.

1 reference

12 December 2020

Liver disease in alpha-1 antitrypsin deficiency: current understanding and future therapy

1 reference

12 December 2020

Alpha-1 antitrypsin deficiency: the European experience

1 reference

12 December 2020

α1-Antitrypsin phenotypes and associated serum protein concentrations in a large clinical population.

1 reference

12 December 2020

Outcomes for recipients of liver transplantation for alpha-1-antitrypsin deficiency–related cirrhosis.

1 reference

12 December 2020

Interactions between SERPINA1 PiMZ genotype, occupational exposure and lung function decline

1 reference

12 December 2020

Clarification of the risk of chronic obstructive pulmonary disease in α1-antitrypsin deficiency PiMZ heterozygotes.

1 reference

12 December 2020

Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update

1 reference

12 December 2020

Actualización sobre indicaciones de búsqueda activa de casos y tratamiento con alfa-1 antitripsina por vía intravenosa en pacientes con enfermedad pulmonar obstructiva crónica asociada a déficit de alfa-1 antitripsina

1 reference

12 December 2020

Lung Function and CT Densitometry in Subjects with alpha-1-Antitrypsin Deficiency and Healthy Controls at 35 Years of Age.

1 reference

12 December 2020

Spanish Registry of Patients With Alpha-1 Antitrypsin Deficiency; Comparison of the Characteristics of PISZ and PIZZ Individuals

1 reference

12 December 2020

Italian registry of patients with alpha-1 antitrypsin deficiency: general data and quality of life evaluation.

1 reference

12 December 2020

Sex differences in alpha-1-antitrypsin deficiency lung disease-analysis from the German registry

1 reference

12 December 2020

Antitrypsin Deficiency Assessment and Programme for Treatment (ADAPT): The United Kingdom Registry

1 reference

12 December 2020

Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.

1 reference

12 December 2020

Diagnosis of alpha-1 antitrypsin deficiency: a population-based study

1 reference

12 December 2020

Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE).

1 reference

12 December 2020

C-reactive protein level predicts mortality in COPD: a systematic review and meta-analysis.

1 reference

12 December 2020

Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years

1 reference

12 December 2020

Alpha-1 antitrypsin Pi*SZ genotype: estimated prevalence and number of SZ subjects worldwide.

1 reference

12 December 2020

The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult

1 reference

12 December 2020

Enhanced liver fibrosis test as a reliable tool for assessing fibrosis in nonalcoholic fatty liver disease in a clinical setting

1 reference

12 December 2020

European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency.

1 reference

12 December 2020

The Effects of Inflammation on Alpha 1 Antitrypsin Levels in a National Screening Cohort

1 reference

12 December 2020

Retrospective analysis of children with α-1 antitrypsin deficiency.

1 reference

12 December 2020

Heteropolymerization of α-1-antitrypsin mutants in cell models mimicking heterozygosity.

1 reference

12 December 2020

Presentation and prognosis of liver disease in alpha-1 antitrypsin deficiency

1 reference

12 December 2020

Serum α1-Antitrypsin Concentration in the Diagnosis of α1-Antitrypsin Deficiency.

1 reference

12 December 2020

Alpha-1 antitrypsin deficiency: outstanding questions and future directions.

1 reference

12 December 2020

Liver disease in adults with α1-antitrypsin deficiency

1 reference

12 December 2020

Genotype is associated with smoking and other key health behaviors among individuals with alpha-1 antitrypsin deficiency-associated lung disease

1 reference

12 December 2020

The European Alpha-1 Research Collaboration (EARCO): a new ERS Clinical Research Collaboration to promote research in alpha-1 antitrypsin deficiency

1 reference

12 December 2020

Comparing Patients with ZZ Versus SZ Alpha-1 Antitrypsin Deficiency: Findings from AlphaNet's Disease Management Program

1 reference

12 December 2020

Intravenous Alpha-1 Antitrypsin Therapy for Alpha-1 Antitrypsin Deficiency: The Current State of the Evidence

1 reference

12 December 2020

Diagnosis and management of α-antitrypsin deficiency in Europe: an expert survey

1 reference

12 December 2020